In conclusion, while the FAS c.-671A>G polymorphism may serve as a biomarker for cervical cancer risk prediction among the Malays, there is a limited usability of the polymorphism as a cervical cancer risk biomarker in other populations.
Subgroup analysis by ethnicity suggested that there was no association between CD95rs1800682 polymorphism and cervical cancer risk in Asians, Caucasians, and Africans.
In summary, the meta-analysis suggests that there is no association between FASA670G polymorphism and susceptibility to cervical cancer in both Caucasians and Asians.